Embodied risk for families with Li-Fraumeni syndrome: Like electricity through my body.


Journal

Social science & medicine (1982)
ISSN: 1873-5347
Titre abrégé: Soc Sci Med
Pays: England
ID NLM: 8303205

Informations de publication

Date de publication:
05 2022
Historique:
received: 17 10 2020
revised: 17 12 2021
accepted: 11 03 2022
pubmed: 4 4 2022
medline: 7 6 2022
entrez: 3 4 2022
Statut: ppublish

Résumé

Experiences of illness change the physical body and embodiments, or the ways in which the world and the self are known through the body. When illness is anticipated, such as with inherited cancer predisposition syndromes, risk becomes embodied and shared in family groups. Embodied risk is experienced whether or not symptoms have manifested. To examine how individuals and families with genetic risk experience the world and understand their disease through their bodies, we employ Li-Fraumeni syndrome (LFS) as an exemplar. LFS is a rare, genetic, cancer predisposition syndrome with nearly 100% lifetime cancer risk starting from birth, limited opportunities for prevention, rigorous screening protocols, and early mortality. Forty-five families, including 117 individuals aged 13-81 years, enrolled in the National Cancer Insitute's LFS study (NCT01443468) completed 66 open-ended interviews regarding LFS experiences. An interdisciplinary team used modified grounded theory to explore physical aspects of living with LFS in psychosocial contexts. The physicality of living with LFS included constant monitoring of LFS bodies across the family to identify physical change that might indicate carcinogenesis. Cancer screening, risk reduction, and treatment acted as dually protective and invasive, and as an unavoidable features of LFS. Connections between family members with similar embodiments normalized aesthetic changes and supported coping with visible markers of difference. In some circumstances, participants objectified the body to preserve the self and important relationships. In others, intense pain or loss created thresholds beyond which the self could no longer be separated from the body to support coping. This paper focuses on Li-Fraumeni syndrome, a familial condition with a well-established genetic identity in which the body-self is experienced in relation to important others, to medical imaging, and to historical experiences with cancer. We expand on theories of embodied risk and inter-embodiment to describe experiences across disease trajectories, with attention to division and union between body, self, and other.

Identifiants

pubmed: 35367908
pii: S0277-9536(22)00211-8
doi: 10.1016/j.socscimed.2022.114905
pmc: PMC9237847
mid: NIHMS1795100
pii:
doi:

Banques de données

ClinicalTrials.gov
['NCT01443468']

Types de publication

Journal Article Research Support, N.I.H., Intramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

114905

Subventions

Organisme : Intramural NIH HHS
ID : Z99 CA999999
Pays : United States

Informations de copyright

Copyright © 2022 Elsevier Ltd. All rights reserved.

Références

Qual Health Res. 2016 Oct;26(12):1614-26
pubmed: 26078328
Health Commun. 2020 Feb;35(2):180-191
pubmed: 30466317
Clin Cancer Res. 2017 Jun 1;23(11):e38-e45
pubmed: 28572266
Cancer Nurs. 2018 Sep/Oct;41(5):E23-E39
pubmed: 28723724
Soc Sci Med. 2011 Feb;72(4):460-8
pubmed: 21216515
Soc Sci Med. 1995 Jul;41(2):173-80
pubmed: 7545314
Health Commun. 2018 Jun;33(6):700-709
pubmed: 28402137
Soc Sci Med. 1998 Nov;47(10):1485-94
pubmed: 9823044
Science. 1990 Nov 30;250(4985):1233-8
pubmed: 1978757
Nurse Res. 2006 Jul 1;13(4):84
pubmed: 27702218
Cancer. 2016 Dec 1;122(23):3673-3681
pubmed: 27496084
Nature. 1990 Dec 20-27;348(6303):747-9
pubmed: 2259385
Soc Sci Med. 1994 Mar;38(6):775-88
pubmed: 8184329
BMC Cancer. 2020 Oct 14;20(1):995
pubmed: 33054722
Nurs Inq. 2003 Sep;10(3):170-6
pubmed: 12940971
Curr Opin Oncol. 2018 Jan;30(1):23-29
pubmed: 29076966
Fam Syst Health. 2009 Sep;27(3):201-12
pubmed: 19803615
J Genet Couns. 2016 Jun;25(3):529-42
pubmed: 26621765
Radiology. 2005 Feb;234(2):339-42
pubmed: 15670989
Fam Cancer. 2020 Jul;19(3):259-268
pubmed: 32222840
J Genet Couns. 1998 Aug;7(4):345-64
pubmed: 26141523
J Med Philos. 1984 Feb;9(1):29-43
pubmed: 6726100
J Med Genet. 2009 Oct;46(10):689-93
pubmed: 19556618
J Genet Couns. 2005 Feb;14(1):55-69
pubmed: 15789156
J Palliat Care. 2014 Spring;30(1):5-15
pubmed: 24826438
Fam Process. 2007 Sep;46(3):335-49
pubmed: 17899857
Aust J Gen Pract. 2021 Aug;50(8):538-544
pubmed: 34333565
Sociol Health Illn. 2013 May;35(4):529-43
pubmed: 22897600
Neurosci Biobehav Rev. 2008;32(1):143-60
pubmed: 17707508
Lancet Oncol. 2016 Sep;17(9):1295-305
pubmed: 27501770
Health Soc Work. 2021 Nov 16;46(4):299-307
pubmed: 34618014
Int J Health Serv. 1993;23(3):425-35
pubmed: 8375947
Soc Sci Med. 1998 Feb;46(3):437-44
pubmed: 9460824
Soc Sci Med. 2017 Oct;191:186-193
pubmed: 28926777
Soc Sci Med. 2015 May;132:141-8
pubmed: 25813728
Genet Test. 2008 Mar;12(1):115-24
pubmed: 18307384
Health (London). 2010 Nov;14(6):653-68
pubmed: 20974697
J Med Genet. 2018 Mar;55(3):173-180
pubmed: 29070607
ANS Adv Nurs Sci. 1999 Dec;22(2):25-38
pubmed: 10634185
Res Nurs Health. 1997 Apr;20(2):169-77
pubmed: 9100747
J Genet Couns. 2020 Oct;29(5):737-747
pubmed: 31872506
Cancer Epidemiol Biomarkers Prev. 2020 May;29(5):927-935
pubmed: 32156722
Soc Sci Med. 2006 Jun;62(11):2720-31
pubmed: 16356616

Auteurs

Allison Werner-Lin (A)

School of Social Policy and Practice, University of Pennsylvania, Philadelphia, PA, USA; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA. Electronic address: awer@upenn.edu.

Rowan Forbes Shepherd (R)

Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA.

Jennifer L Young (JL)

Stanford Center for Biomedical Ethics, Stanford University, Stanford, CA, USA.

Catherine Wilsnack (C)

Steve Hicks School of Social Work, The University of Texas at Austin, Austin, TX, USA.

Shana L Merrill (SL)

School of Social Policy and Practice, University of Pennsylvania, Philadelphia, PA, USA; Hospital of the University of Pennsylvania, Philadelphia, PA, USA.

Mark H Greene (MH)

Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA.

Payal P Khincha (PP)

Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH